Published in J Infect on January 01, 1997
Autoantibodies to human cytosol: a marker of sporadic porphyria cutanea tarda. Clin Exp Immunol (2001) 0.75
S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol (1999) 2.14
Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology (1995) 2.02
Systematic review: hepatitis-associated aplastic anaemia--a syndrome associated with abnormal immunological function. Aliment Pharmacol Ther (2009) 1.83
Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol (2000) 1.74
A pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty liver patients. Aliment Pharmacol Ther (2006) 1.74
Schnitzler's syndrome with monoclonal IgG kappa gammopathy: good response to cyclosporin. J Eur Acad Dermatol Venereol (2002) 1.73
Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J Exp Med (1994) 1.66
Lichen planus with lesions on the palms and/or soles: prevalence and clinicopathological study of 36 patients. Br J Dermatol (2000) 1.58
Tonsillectomy and inflammatory bowel disease location. Eur J Gastroenterol Hepatol (1996) 1.57
[Utility of analytical parameters in the diagnosis of liver disease]. An Med Interna (2007) 1.40
Chronic hepatitis C in children: a clinical and immunohistochemical comparative study with adult patients. Hepatology (1998) 1.39
Recall phenomenon with the unusual presence of eccrine squamous syringometaplasia. Br J Dermatol (1995) 1.39
Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease. J Hepatol (2000) 1.36
6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease. Eur J Gastroenterol Hepatol (2000) 1.34
The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes. Hepatology (1998) 1.27
Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology (1993) 1.23
Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy. Clin Endocrinol (Oxf) (1996) 1.19
Tetraspanins are localized at motility-related structures and involved in normal human keratinocyte wound healing migration. J Invest Dermatol (2000) 1.19
Massive scrotal calcinosis. Dermatol Surg (2002) 1.15
Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression. J Proteome Res (2012) 1.14
Spiral CT findings in active and remission phases in patients with Crohn disease. J Comput Assist Tomogr (2001) 1.14
Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents. Aliment Pharmacol Ther (2008) 1.12
Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Aliment Pharmacol Ther (2006) 1.11
Expression of a novel activation antigen on intrahepatic CD8+ T lymphocytes in viral chronic active hepatitis. Gastroenterology (1990) 1.10
Liver fibrosis assessment by transient elastography in hepatitis C patients with normal alanine aminotransferase. Gut (2006) 1.09
Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation. J Clin Invest (1998) 1.09
Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts. Gastroenterology (1995) 1.08
Usefulness of manometry to select patients with anal fissure for controlled anal dilatation. Rev Esp Enferm Dig (2010) 1.07
Effect of the hepatitis B virus HBx protein on integrin-mediated adhesion to and migration on extracellular matrix. J Hepatol (2001) 1.05
S-Adenosylmethionine modulates inducible nitric oxide synthase gene expression in rat liver and isolated hepatocytes. J Hepatol (2001) 1.01
Lichen planus and hepatitis C virus: prevalence and clinical presentation of patients with lichen planus and hepatitis C virus infection. Br J Dermatol (1996) 0.99
Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection. Aliment Pharmacol Ther (2005) 0.98
Hirsutism secondary to topical testosterone: report of two cases and review of the literature. J Eur Acad Dermatol Venereol (2004) 0.97
Allergic contact dermatitis to polyethylene glycol and nitrofurazone. Am J Contact Dermat (1999) 0.97
Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients. Aliment Pharmacol Ther (2007) 0.97
Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures. Aliment Pharmacol Ther (2006) 0.96
Sweet's syndrome on the area of postmastectomy lymphoedema. J Eur Acad Dermatol Venereol (2006) 0.96
Gene expression profile of T-cell-specific chemokines in human hepatocyte-derived cells: evidence for a synergistic inducer effect of cytokines and hepatitis C virus proteins. J Viral Hepat (2005) 0.95
The Spanish version of Skindex-29. Int J Dermatol (2000) 0.95
Increased circulating and intrahepatic T-cell-specific chemokines in chronic hepatitis C: relationship with the type of virological response to peginterferon plus ribavirin combination therapy. Aliment Pharmacol Ther (2004) 0.95
Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin. Dig Liver Dis (2009) 0.94
Down-regulation of intercellular adhesion molecule 1 on hepatocytes in viral chronic hepatitis treated with interferon alfa-2b. Gastroenterology (1993) 0.93
Perforating granuloma annulare. Int J Dermatol (1997) 0.93
Ross syndrome, an entity included within the spectrum of partial disautonomic syndromes. J Eur Acad Dermatol Venereol (2005) 0.93
Ustekinumab: effective in a patient with severe recalcitrant generalized pustular psoriasis. Br J Dermatol (2010) 0.92
Soluble adhesion molecules correlate with liver inflammation and fibrosis in chronic hepatitis C treated with interferon-alpha. Aliment Pharmacol Ther (1998) 0.92
Increased intrahepatic and circulating levels of endoglin, a TGF-beta1 co-receptor, in patients with chronic hepatitis C virus infection: relationship to histological and serum markers of hepatic fibrosis. J Viral Hepat (2006) 0.91
Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis. Aliment Pharmacol Ther (2007) 0.89
Evaluation of liver fibrosis by transient elastography (Fibroscan®) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial. Scand J Gastroenterol (2012) 0.89
Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia. Aliment Pharmacol Ther (1999) 0.88
Association of Helicobacter pylori infection with psoriasis and lichen planus: prevalence and effect of eradication therapy. Arch Dermatol (2000) 0.87
Fixed drug eruption due to loratadine. Br J Dermatol (2002) 0.87
Intrahepatic expression of inducible nitric oxide synthase in acute liver allograft rejection: evidence of modulation by corticosteroids. Liver Transpl (2001) 0.87
Mucinous metaplasia of the glans penis. Histopathology (2004) 0.87
Eruptive pruritic syringomas: treatment with topical atropine. J Am Acad Dermatol (2001) 0.87
Genetic variants of interferon-stimulated genes and IL-28B as host prognostic factors of response to combination treatment for chronic hepatitis C. Clin Pharmacol Ther (2011) 0.87
Review article: immunopathogenetic and therapeutic aspects of autoimmune hepatitis. Aliment Pharmacol Ther (2003) 0.86
Unusual clinical presentation of amyloidosis: bilateral stenosis of the external auditory canal, hoarseness and a rapid course of cutaneous lesions. Int J Dermatol (2007) 0.86
Variability in the expression of a beta 2-microglobulin epitope on hepatocytes in chronic type C hepatitis on treatment with interferon. Hepatology (1993) 0.85
Helicobacter pylori and idiopathic chronic urticaria. Int J Dermatol (2000) 0.85
Lupus erythematosus-like lesions in a carrier of X-linked chronic granulomatous disease. J Eur Acad Dermatol Venereol (2000) 0.85
[Predisposing and precipitating factors in Mallory-Weiss syndrome]. Rev Esp Enferm Apar Dig (1984) 0.83
Flare and change of psoriasis morphology during the course of treatment with tumour necrosis factor blockers. Clin Exp Dermatol (2006) 0.83
Development of cirrhosis after chronic type B hepatitis: a clinicopathologic and follow-up study of 46 HBeAg-positive asymptomatic patients. Am J Gastroenterol (1991) 0.83
Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis. Br J Dermatol (2012) 0.82
Atypical pityriasis rosea and Hodgkin's disease. J Eur Acad Dermatol Venereol (2004) 0.82
Madelung's disease involving the tongue. J Am Acad Dermatol (2000) 0.82